Brief: Pharvaris Provides Clinical And Corporate Updates
09/01/2023 12:58
Jan 9 (Reuters) - Pharvaris NV PHVS.O :
* PHARVARIS PROVIDES REGULATORY, CLINICAL, AND CORPORATE
UPDATES
* PHARVARIS NV - REMAINS DILIGENT IN ITS OPERATIONAL
MANAGEMENT
AND IS FOCUSING ON ITS EXISTING CLINICAL HAE PIPELINE TO EXTEND
RUNWAY INTO 4Q 2024
Source text for Eikon: ID:nGNX6JpZsn
Further company coverage: PHVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharvaris
See all newsU.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, Novartis
Pharvaris gains after genetic disorder drug meets late-stage trial goal